These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5142139)

  • 21. [Electron-microscopic findings, and photometric and activation-analytical results in experimental caridac insufficiency caused by cobaltous chloride].
    Knieriem HJ; Herbertz G
    Virchows Arch B Cell Pathol; 1969; 2(1):32-46. PubMed ID: 4979970
    [No Abstract]   [Full Text] [Related]  

  • 22. Anthracycline cardiomyopathy in children: report of two cases.
    Mosijczuk AD; Ruymann FB; Mease AD; Bernier RD
    Cancer; 1979 Nov; 44(5):1582-7. PubMed ID: 291472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of acute anthracycline cardiotoxicity in isolated rat hearts: carminomycin versus daunomycin.
    Saman S; Jacobs P; Opie LH
    Cancer Res; 1984 Apr; 44(4):1316-20. PubMed ID: 6704950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat].
    Semenov DE; Nepomniashchikh LM; Semenova LA
    Biull Eksp Biol Med; 1987 Jul; 104(7):113-6. PubMed ID: 3620638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical signs and natural history of alcoholic heart disease.
    Gunnar RM; Demakis J; Rahimtoola SH; Sinno MZ; Tobin JR
    Ann N Y Acad Sci; 1975 Apr; 252():264-72. PubMed ID: 125061
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiotoxic effects of drugs and various other substances. A review].
    Mono G; Kuhn E
    Fortschr Med; 1978 Apr; 96(14):765-70. PubMed ID: 25235
    [No Abstract]   [Full Text] [Related]  

  • 29. [Daunomycin and atrial fibrillation].
    Fuster Siebert M; Fernández Iglesias A; Couselo Sánchez JM; Gallego García D; Iglesias Diz JL; Alvez González F
    An Esp Pediatr; 1983 Nov; 19(5):415-6. PubMed ID: 6581751
    [No Abstract]   [Full Text] [Related]  

  • 30. Osseous changes and abnormalities of mineral metabolism in daunomycin rats.
    Shimizu K; Maeda K; Shibata M; Ise M; Sugano M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):863-9. PubMed ID: 2250403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J; Prochaczek F; Holowiecki J; Stella B
    Acta Haematol Pol; 1976; 7(3):195-8. PubMed ID: 983667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathological anatomy in heart insufficiency].
    Meessen H
    Arztl Forsch; 1967 Feb; 21(2):41-50. PubMed ID: 4873357
    [No Abstract]   [Full Text] [Related]  

  • 33. Daunorubicin-induced cardiotoxicity.
    Morgan OS; Amin UF; Gibbs WN
    West Indian Med J; 1976 Mar; 25(1):58-63. PubMed ID: 1266211
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Dziegiel P; Jethon Z; Suder E; Sopel M; Rabczyński J; Surowiak P; Zabel M
    Exp Toxicol Pathol; 2002 Feb; 53(6):433-9. PubMed ID: 11926284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic changes induced by daunomycin (NSC-82151) in the Syrian golden hamster.
    Farmar RM; Herman EH; Schein P
    Cancer Chemother Rep; 1970 Feb; 54(1):15-22. PubMed ID: 5527011
    [No Abstract]   [Full Text] [Related]  

  • 36. Daunomycin.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 10():145-52. PubMed ID: 791796
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL; Bonnet-Gajdos M; Mougenot B
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract]   [Full Text] [Related]  

  • 38. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats.
    Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
    Free Radic Res; 2010 Nov; 44(11):1369-77. PubMed ID: 20815778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F; Plouvier B; Breviere G; Goudemand M
    Sem Hop; 1975 Jun; 51(28):1949-57. PubMed ID: 180611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electron microscopic picture of the heart muscle in acute hypoxic cardiac insufficiency].
    Büchner F; Onishi S
    Naturwissenschaften; 1967 Jan; 54(1):22. PubMed ID: 5591305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.